KI
Kilitch Drugs (India) Limited
KILITCH.BO · BSE
₹184.15 -2.62% (-₹4.95)
1M -3.52%
Market Cap ₹6.61B
P/E Ratio 22.00x
Div. Yield -
ROE 11.90%
Bulios Fair Price
₹117.21
36.4% downside
Current Price
₹184.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, KILITCH.BO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
53 /100
Fair EV/EBITDA 16.88x
P/S 2.79x
P/B 2.36x
Growth
100 /100
Growing Rev. growth 19.04%
Book val. growth 22.64%
EPS growth 39.46%
Profitability
48 /100
Moderate Net margin 12.67%
Op. margin 13.66%
FCF margin 24.50%
Quality
46 /100
Average ROE 11.90%
ROA 6.57%
Asset turnover 0.52x
Debt
83 /100
Low Current ratio 1.83x
Int. coverage 8.06x
Net debt/EBITDA 1.66x
Stability
70 /100
Stable Rev. volatility 9.55%
EPS volatility 36.02%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about KILITCH.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mukund Prataprai Mehta
Employees
236
Headquarters
Mumbai